Women taking other agents for hot flashes, hormonal therapy other than tamoxifen, or antidepressants were excluded. The primary endpoints, hot flash frequency and severity, were documented in ...

Primary and review articles published in English were identified by a MEDLINE (1966-June 2003) search using the MeSH terms "hot flashes," "hot flushes," "menopause," and "serotonin reuptake inhibitor.

Research suggests that antidepressants may help treat menopausal symptoms, such as hot flashes and night sweats. Antidepressants are medications that help treat symptoms of depression. Most impact ...

If you have menopause symptoms like hot flashes, night sweats, brain fog, you want relief. Can menopause supplements help?

Often advertised to help with hot flashes and depression, St. Johns wort can also interact with many other medications that can have an impact on someone’s health, Christmas says. Some products ...

The first documentary film that addresses the marginalized or ignored health crisis faced by millions of women as they go ...

Dealing with Depression is a workbook for teens that explains depression and teaches three main antidepressant skills you can use to help overcome or prevent it. The skills are presented in a ...

The matchup: Two doses of psilocybin, the active ingredient in “magic mushrooms,” against a six-week course of the popular antidepressant escitalopram, often sold as Lexapro or Cipralex.

The answer involves two baby chickens and ... At-Home Brain Stimulation for Depression Is Safe and Effective, According to Researchers Oct. 21, 2024 — A device that delivers direct stimulation ...

(CNN) — The matchup: Two doses of psilocybin, the active ingredient in “magic mushrooms,” against a six-week course of the popular antidepressant escitalopram, often sold as Lexapro or Cipralex.

You have plenty of company. According to a recent study, when stock prices fall, the number of antidepressant prescriptions rises. The researchers examined the connection by first creating local ...

In the ESCAPE-TRD study, Spravato outperformed quetiapine on the main endpoint of achieving remission at eight weeks, measured by the Montgomery-Åsberg Depression Rating Scale (MADRS), with rates ...